These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study. Fattom A, Matalon A, Buerkert J, Taylor K, Damaso S, Boutriau D. Hum Vaccin Immunother; 2015 Jan; 11(3):632-41. PubMed ID: 25483694 [Abstract] [Full Text] [Related]
7. Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX) in hemodialysis patients. Fattom A, Fuller S, Propst M, Winston S, Muenz L, He D, Naso R, Horwith G. Vaccine; 2004 Dec 16; 23(5):656-63. PubMed ID: 15542186 [Abstract] [Full Text] [Related]
9. Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials. Fattom AI, Horwith G, Fuller S, Propst M, Naso R. Vaccine; 2004 Feb 17; 22(7):880-7. PubMed ID: 15040941 [Abstract] [Full Text] [Related]
10. Sipuleucel-T: APC 8015, APC-8015, prostate cancer vaccine--Dendreon. Drugs R D; 2006 Feb 17; 7(3):197-201. PubMed ID: 16752945 [Abstract] [Full Text] [Related]
11. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. Shinefield H, Black S, Fattom A, Horwith G, Rasgon S, Ordonez J, Yeoh H, Law D, Robbins JB, Schneerson R, Muenz L, Fuller S, Johnson J, Fireman B, Alcorn H, Naso R. N Engl J Med; 2002 Feb 14; 346(7):491-6. PubMed ID: 11844850 [Abstract] [Full Text] [Related]